Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

BACKGROUND: Recently, basic and clinical studies have provided evidence supporting the relationship between circulating levels of fibroblast growth factor (FGF) 23 and the development of atherosclerosis. Given that diabetes is an established risk factor for lower extremity atherosclerotic disease (L...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: He, Xingxing, Hu, Xiang, Ma, Xiaojing, Su, Hang, Ying, Lingwen, Peng, Jiahui, Pan, Xiaoping, Bao, Yuqian, Zhou, Jian, Jia, Weiping
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5472967/
https://ncbi.nlm.nih.gov/pubmed/28619026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0559-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars